Tempus AI (NASDAQ:TEM) Shares Gap Up – Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares gapped up prior to trading on Monday . The stock had previously closed at $66.27, but opened at $75.34. Tempus AI shares last traded at $72.5350, with a volume of 4,387,169 shares trading hands.

Analysts Set New Price Targets

A number of research firms recently issued reports on TEM. BTIG Research boosted their target price on shares of Tempus AI from $96.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Canaccord Genuity Group dropped their price objective on Tempus AI from $95.00 to $80.00 and set a “buy” rating for the company in a report on Monday, December 22nd. Morgan Stanley increased their target price on Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a research report on Monday, December 1st. TD Cowen lowered Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target for the company. in a research note on Tuesday, October 21st. Finally, Guggenheim lifted their price objective on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $84.00.

Tempus AI Trading Up 3.6%

The firm has a fifty day moving average of $70.25 and a 200 day moving average of $73.41. The firm has a market capitalization of $12.21 billion, a PE ratio of -57.68 and a beta of 5.22. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI’s revenue for the quarter was up 84.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.46) earnings per share. Equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insiders Place Their Bets

In other Tempus AI news, CFO James William Rogers sold 19,966 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the completion of the transaction, the chief financial officer directly owned 111,250 shares of the company’s stock, valued at $8,143,500. This trade represents a 15.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Ryan Fukushima sold 10,099 shares of the stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $661,888.46. Following the transaction, the chief operating officer directly owned 829,081 shares in the company, valued at $54,337,968.74. The trade was a 1.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 932,832 shares of company stock worth $71,184,024. 26.27% of the stock is owned by insiders.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC lifted its position in shares of Tempus AI by 903.7% during the 4th quarter. SG Americas Securities LLC now owns 372,043 shares of the company’s stock valued at $21,969,000 after acquiring an additional 334,975 shares during the last quarter. Green Alpha Advisors LLC grew its holdings in shares of Tempus AI by 1.3% in the 4th quarter. Green Alpha Advisors LLC now owns 46,352 shares of the company’s stock worth $2,737,000 after acquiring an additional 577 shares during the last quarter. Allworth Financial LP raised its position in shares of Tempus AI by 73.9% during the third quarter. Allworth Financial LP now owns 798 shares of the company’s stock worth $64,000 after purchasing an additional 339 shares during the period. IFP Advisors Inc lifted its holdings in shares of Tempus AI by 140.1% during the third quarter. IFP Advisors Inc now owns 4,274 shares of the company’s stock valued at $345,000 after purchasing an additional 2,494 shares during the last quarter. Finally, Swiss Life Asset Management Ltd acquired a new position in shares of Tempus AI in the 3rd quarter valued at $349,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.